Why the study?
Do alternative antihypertensive agents (other than diuretics alone) improve cardiovascular and metabolic outcomes in black American hypertensive patients?
Do alternative antihypertensive agents (other than diuretics alone) improve cardiovascular and metabolic outcomes in black American hypertensive patients?
This review emphasizes the importance of considering metabolic and cardiovascular risk factors when selecting antihypertensive therapies beyond diuretics for black American patients.
No takes yet. Share an insight, caveat, or question.
Supports considering non-diuretic antihypertensives in black patients; leaves open dedicated RCTs to confirm cardiovascular benefits.
Myron H. Weinberger (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: